Search hospitals > Texas > Fort Worth

The Center For Cancer and Blood Disorders

Claim this profile
Fort Worth, Texas 76104
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Pancreatic Cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
101 reported clinical trials
2 medical researchers
Photo of The Center For Cancer and Blood Disorders in Fort WorthPhoto of The Center For Cancer and Blood Disorders in Fort WorthPhoto of The Center For Cancer and Blood Disorders in Fort Worth

Summary

The Center For Cancer and Blood Disorders is a medical facility located in Fort Worth, Texas. This center is recognized for care of Breast Cancer, Lung Cancer, Pancreatic Cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. The Center For Cancer and Blood Disorders is involved with conducting 101 clinical trials across 105 conditions. There are 2 research doctors associated with this hospital, such as Ray D Page and Robyn R Young, MD.

Area of expertise

1Breast Cancer
Global Leader
The Center For Cancer and Blood Disorders has run 42 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
Stage III
HER2 negative
2Lung Cancer
Global Leader
The Center For Cancer and Blood Disorders has run 20 trials for Lung Cancer. Some of their research focus areas include:
Stage III
Stage IV
Stage II

Top PIs

Clinical Trials running at The Center For Cancer and Blood Disorders

Breast Cancer
Bladder Cancer
Ovarian Cancer
Lung Cancer
Kidney Cancer
Chronic Lymphocytic Leukemia
Squamous Cell Carcinoma
Esophageal Cancer
Rectal Cancer
Non-Small Cell Lung Cancer
Image of trial facility.

Sacituzumab Tirumotecan + Pembrolizumab

for Breast Cancer

The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Recruiting2 awards Phase 33 criteria
Image of trial facility.

Imlunestrant

for Early Breast Cancer

This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Guardant Reveal

for Cancer

The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and explore its value in a healthcare environment subject to cost containment.
Recruiting1 award N/A10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at The Center For Cancer and Blood Disorders?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security